BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Fois AG, Paliogiannis P, Sotgia S, Mangoni AA, Zinellu E, Pirina P, Carru C, Zinellu A. Evaluation of oxidative stress biomarkers in idiopathic pulmonary fibrosis and therapeutic applications: a systematic review. Respir Res 2018;19:51. [PMID: 29587761 DOI: 10.1186/s12931-018-0754-7] [Cited by in Crossref: 38] [Cited by in F6Publishing: 35] [Article Influence: 9.5] [Reference Citation Analysis]
Number Citing Articles
1 Saito S, Alkhatib A, Kolls JK, Kondoh Y, Lasky JA. Pharmacotherapy and adjunctive treatment for idiopathic pulmonary fibrosis (IPF). J Thorac Dis 2019;11:S1740-54. [PMID: 31632751 DOI: 10.21037/jtd.2019.04.62] [Cited by in Crossref: 30] [Cited by in F6Publishing: 28] [Article Influence: 10.0] [Reference Citation Analysis]
2 Krauss E, Froehler M, Degen M, Mahavadi P, Dartsch RC, Korfei M, Ruppert C, Seeger W, Guenther A. Exhalative Breath Markers Do Not Offer for Diagnosis of Interstitial Lung Diseases: Data from the European IPF Registry (eurIPFreg) and Biobank. J Clin Med 2019;8:E643. [PMID: 31075945 DOI: 10.3390/jcm8050643] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
3 Fois SS, Canu S, Fois AG. The Role of Oxidative Stress in Sarcoidosis. Int J Mol Sci 2021;22:11712. [PMID: 34769145 DOI: 10.3390/ijms222111712] [Reference Citation Analysis]
4 Zhang Y, Zhao M, Guo P, Wang Y, Liu L, Zhao J, Gao L, Yuan Z, Xue F, Zhao J. Mendelian randomisation highlights hypothyroidism as a causal determinant of idiopathic pulmonary fibrosis. EBioMedicine 2021;73:103669. [PMID: 34749302 DOI: 10.1016/j.ebiom.2021.103669] [Reference Citation Analysis]
5 Xu M, Wang X, Xu L, Zhang H, Li C, Liu Q, Chen Y, Chung KF, Adcock IM, Li F. Chronic lung inflammation and pulmonary fibrosis after multiple intranasal instillation of PM2 .5 in mice. Environ Toxicol 2021;36:1434-46. [PMID: 33780121 DOI: 10.1002/tox.23140] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
6 Wallach-Dayan SB, Petukhov D, Ahdut-HaCohen R, Richter-Dayan M, Breuer R. sFasL-The Key to a Riddle: Immune Responses in Aging Lung and Disease. Int J Mol Sci 2021;22:2177. [PMID: 33671651 DOI: 10.3390/ijms22042177] [Reference Citation Analysis]
7 Cameli P, Carleo A, Bergantini L, Landi C, Prasse A, Bargagli E. Oxidant/Antioxidant Disequilibrium in Idiopathic Pulmonary Fibrosis Pathogenesis. Inflammation 2020;43:1-7. [DOI: 10.1007/s10753-019-01059-1] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 6.0] [Reference Citation Analysis]
8 Carpagnano GE, Soccio P, Scioscia G, Palladino GP, Foschino Barbaro MP, Lacedonia D. The Potential Role of Airways Periostin in the Clinical Practice of Patients Affected by Idiopathic Pulmonary Fibrosis. Rejuvenation Res 2021;24:302-6. [PMID: 33749341 DOI: 10.1089/rej.2020.2401] [Reference Citation Analysis]
9 Wu B, Tang L, Kapoor M. Fibroblasts and their responses to chronic injury in pulmonary fibrosis. Semin Arthritis Rheum 2021;51:310-7. [PMID: 33440304 DOI: 10.1016/j.semarthrit.2020.12.003] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
10 Schapochnik A, da Silva MR, Leal MP, Esteves J, Hebeda CB, Sandri S, de Fátima Teixeira da Silva D, Farsky SHP, Marcos RL, Lino-Dos-Santos-Franco A. Vitamin D treatment abrogates the inflammatory response in paraquat-induced lung fibrosis. Toxicol Appl Pharmacol 2018;355:60-7. [PMID: 29944852 DOI: 10.1016/j.taap.2018.06.020] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 3.3] [Reference Citation Analysis]
11 Assayag M, Goldstein S, Samuni A, Berkman N. 3-Carbamoyl-proxyl nitroxide radicals attenuate bleomycin-induced pulmonary fibrosis in mice. Free Radic Biol Med 2021;171:135-42. [PMID: 33989760 DOI: 10.1016/j.freeradbiomed.2021.05.010] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
12 Smith CJ, Perfetti TA, King JA. Indirect oxidative stress from pulmonary inflammation exceeds direct oxidative stress from chemical damage to mitochondria. Toxicology Research and Application 2019;3:239784731984284. [DOI: 10.1177/2397847319842845] [Reference Citation Analysis]
13 Hedayati-Moghadam M, Rezaee SAR, Boskabady MH, Mohamadian Roshan N, Saadat S, Bavarsad K, Niazmand S. Human T-Cell Leukemia Virus Type 1 Changes Leukocyte Number and Oxidative Stress in the Lung and Blood of Female BALB/c Mice. Adv Biomed Res 2021;10:6. [PMID: 33959563 DOI: 10.4103/abr.abr_117_20] [Reference Citation Analysis]
14 Chen F, Gao Q, Zhang L, Ding Y, Wang H, Cao W. Inhibiting HDAC3 (Histone Deacetylase 3) Aberration and the Resultant Nrf2 (Nuclear Factor Erythroid-Derived 2-Related Factor-2) Repression Mitigates Pulmonary Fibrosis. Hypertension 2021;78:e15-25. [PMID: 34148362 DOI: 10.1161/HYPERTENSIONAHA.121.17471] [Reference Citation Analysis]
15 Nojima Y, Takeda Y, Maeda Y, Bamba T, Fukusaki E, Itoh MN, Mizuguchi K, Kumanogoh A. Metabolomic analysis of fibrotic mice combined with public RNA-Seq human lung data reveal potential diagnostic biomarker candidates for lung fibrosis. FEBS Open Bio 2020;10:2427-36. [PMID: 32961634 DOI: 10.1002/2211-5463.12982] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
16 Phan THG, Paliogiannis P, Nasrallah GK, Giordo R, Eid AH, Fois AG, Zinellu A, Mangoni AA, Pintus G. Emerging cellular and molecular determinants of idiopathic pulmonary fibrosis. Cell Mol Life Sci 2021;78:2031-57. [PMID: 33201251 DOI: 10.1007/s00018-020-03693-7] [Cited by in Crossref: 11] [Cited by in F6Publishing: 15] [Article Influence: 5.5] [Reference Citation Analysis]
17 Smith CJ, Perfetti TA, King JA. Bronchioloalveolar lung tumors induced in “mice only” by non-genotoxic chemicals are not useful for quantitative assessment of pulmonary adenocarcinoma risk in humans. Toxicology Research and Application 2018;2:239784731881661. [DOI: 10.1177/2397847318816617] [Reference Citation Analysis]
18 Tew XN, Xin Lau NJ, Chellappan DK, Madheswaran T, Zeeshan F, Tambuwala MM, Aljabali AA, Balusamy SR, Perumalsamy H, Gupta G, Oliver BG, Hsu A, Wark P, Reddy K, Wadhwa R, Hansbro PM, Dua K. Immunological axis of berberine in managing inflammation underlying chronic respiratory inflammatory diseases. Chem Biol Interact 2020;317:108947. [PMID: 31968208 DOI: 10.1016/j.cbi.2020.108947] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
19 Ke S, Zhang Y, Lan Z, Li S, Zhu W, Liu L. Curcumin protects murine lung mesenchymal stem cells from H2O2 by modulating the Akt/Nrf2/HO-1 pathway. J Int Med Res 2020;48:300060520910665. [PMID: 32237999 DOI: 10.1177/0300060520910665] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
20 Sharma A, Tewari D, Nabavi SF, Nabavi SM, Habtemariam S. Reactive oxygen species modulators in pulmonary medicine. Curr Opin Pharmacol 2021;57:157-64. [PMID: 33743400 DOI: 10.1016/j.coph.2021.02.005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
21 Assayag M, Goldstein S, Samuni A, Kaufman A, Berkman N. The nitroxide/antioxidant 3-carbamoyl proxyl attenuates disease severity in murine models of severe asthma. Free Radic Biol Med 2021;177:181-8. [PMID: 34678420 DOI: 10.1016/j.freeradbiomed.2021.10.021] [Reference Citation Analysis]
22 Audousset C, McGovern T, Martin JG. Role of Nrf2 in Disease: Novel Molecular Mechanisms and Therapeutic Approaches - Pulmonary Disease/Asthma. Front Physiol 2021;12:727806. [PMID: 34658913 DOI: 10.3389/fphys.2021.727806] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
23 Boots AW, Veith C, Albrecht C, Bartholome R, Drittij MJ, Claessen SMH, Bast A, Rosenbruch M, Jonkers L, van Schooten FJ, Schins RPF. The dietary antioxidant quercetin reduces hallmarks of bleomycin-induced lung fibrogenesis in mice. BMC Pulm Med 2020;20:112. [PMID: 32349726 DOI: 10.1186/s12890-020-1142-x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
24 Hayton C, Terrington D, Wilson AM, Chaudhuri N, Leonard C, Fowler SJ. Breath biomarkers in idiopathic pulmonary fibrosis: a systematic review. Respir Res 2019;20:7. [PMID: 30634961 DOI: 10.1186/s12931-019-0971-8] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 3.7] [Reference Citation Analysis]
25 Sato Y, Tanino Y, Nikaido T, Togawa R, Kawamata T, Wang X, Fukuhara N, Tomita H, Saito M, Watanabe N, Rikimaru M, Umeda T, Morimoto J, Koizumi T, Suzuki Y, Hirai K, Uematsu M, Minemura H, Fukuhara A, Sato S, Saito J, Kanazawa K, Shibata Y. Clinical significance of thyroid hormone and antibodies in patients with idiopathic interstitial pneumonia. J Thorac Dis 2020;12:522-37. [PMID: 32274118 DOI: 10.21037/jtd.2020.01.02] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
26 Fois AG, Sotgiu E, Scano V, Negri S, Mellino S, Zinellu E, Pirina P, Pintus G, Carru C, Mangoni AA, Zinellu A. Effects of Pirfenidone and Nintedanib on Markers of Systemic Oxidative Stress and Inflammation in Patients with Idiopathic Pulmonary Fibrosis: A Preliminary Report. Antioxidants (Basel) 2020;9:E1064. [PMID: 33143144 DOI: 10.3390/antiox9111064] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
27 Siekacz K, Piotrowski WJ, Iwański MA, Górski P, Białas AJ. The Role of Interaction between Mitochondria and the Extracellular Matrix in the Development of Idiopathic Pulmonary Fibrosis. Oxid Med Cell Longev 2021;2021:9932442. [PMID: 34707784 DOI: 10.1155/2021/9932442] [Reference Citation Analysis]
28 Gupta D, Kumar A, Mandloi A, Shenoy V. Renin angiotensin aldosterone system in pulmonary fibrosis: Pathogenesis to therapeutic possibilities. Pharmacol Res 2021;174:105924. [PMID: 34607005 DOI: 10.1016/j.phrs.2021.105924] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
29 Sotgia S, Fois AG, Paliogiannis P, Carru C, Mangoni AA, Zinellu A. Methodological Fallacies in the Determination of Serum/Plasma Glutathione Limit Its Translational Potential in Chronic Obstructive Pulmonary Disease. Molecules 2021;26:1572. [PMID: 33809301 DOI: 10.3390/molecules26061572] [Reference Citation Analysis]
30 Karamalakova Y, Stefanov I, Georgieva E, Nikolova G. Pulmonary Protein Oxidation and Oxidative Stress Modulation by Lemna minor L. in Progressive Bleomycin-Induced Idiopathic Pulmonary Fibrosis. Antioxidants 2022;11:523. [DOI: 10.3390/antiox11030523] [Reference Citation Analysis]
31 Tong B, Fu L, Hu B, Zhang ZC, Tan ZX, Li SR, Chen YH, Zhang C, Wang H, Xu DX, Zhao H. Tauroursodeoxycholic acid alleviates pulmonary endoplasmic reticulum stress and epithelial-mesenchymal transition in bleomycin-induced lung fibrosis. BMC Pulm Med 2021;21:149. [PMID: 33952237 DOI: 10.1186/s12890-021-01514-6] [Reference Citation Analysis]
32 Barnes PJ. Pulmonary Diseases and Ageing. In: Harris JR, Korolchuk VI, editors. Biochemistry and Cell Biology of Ageing: Part II Clinical Science. Singapore: Springer; 2019. pp. 45-74. [DOI: 10.1007/978-981-13-3681-2_3] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 4.3] [Reference Citation Analysis]
33 Checa J, Aran JM. Airway Redox Homeostasis and Inflammation Gone Awry: From Molecular Pathogenesis to Emerging Therapeutics in Respiratory Pathology. Int J Mol Sci 2020;21:E9317. [PMID: 33297418 DOI: 10.3390/ijms21239317] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
34 Pau MC, Zinellu E, Fois SS, Piras B, Pintus G, Carru C, Mangoni AA, Fois AG, Zinellu A, Pirina P. Circulating Malondialdehyde Concentrations in Obstructive Sleep Apnea (OSA): A Systematic Review and Meta-Analysis with Meta-Regression. Antioxidants (Basel) 2021;10:1053. [PMID: 34210032 DOI: 10.3390/antiox10071053] [Reference Citation Analysis]
35 Dosumu OA, Rotimi SO, Akintunde J, Adeleye OO, Sani LO, Omotosho OO, Osinuga KT, Taiwo OA, Ojo OA. Effects of vitamin K dietary supplementation in pulmonary dysfunction induced by 7,12-dimethylbenz[a]anthracene in rat. J Biochem Mol Toxicol 2020;34:e22584. [PMID: 32662551 DOI: 10.1002/jbt.22584] [Reference Citation Analysis]
36 Mattoo H, Pillai S. Idiopathic pulmonary fibrosis and systemic sclerosis: pathogenic mechanisms and therapeutic interventions. Cell Mol Life Sci 2021;78:5527-42. [PMID: 34145462 DOI: 10.1007/s00018-021-03874-y] [Reference Citation Analysis]
37 Magallón M, Carrión AE, Bañuls L, Pellicer D, Castillo S, Bondía S, Navarro-García MM, González C, Dasí F. Oxidative Stress and Endoplasmic Reticulum Stress in Rare Respiratory Diseases. J Clin Med 2021;10:1268. [PMID: 33803835 DOI: 10.3390/jcm10061268] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
38 Forte G, Bocca B, Pisano A, Collu C, Farace C, Sabalic A, Senofonte M, Fois AG, Mazzarello VL, Pirina P, Madeddu R. The levels of trace elements in sputum as biomarkers for idiopathic pulmonary fibrosis. Chemosphere 2021;271:129514. [PMID: 33434828 DOI: 10.1016/j.chemosphere.2020.129514] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
39 Abidi A, Kourda N, Feki M, Ben Khamsa S. Protective Effect of Tunisian Flaxseed Oil against Bleomycin-Induced Pulmonary Fibrosis in Rats. Nutrition and Cancer 2020;72:226-38. [DOI: 10.1080/01635581.2019.1622741] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
40 Reyes-Jiménez E, Ramírez-Hernández AA, Santos-Álvarez JC, Velázquez-Enríquez JM, Pina-Canseco S, Baltiérrez-Hoyos R, Vásquez-Garzón VR. Involvement of 4-hydroxy-2-nonenal in the pathogenesis of pulmonary fibrosis. Mol Cell Biochem 2021;476:4405-19. [PMID: 34463938 DOI: 10.1007/s11010-021-04244-9] [Reference Citation Analysis]
41 Veith C, Boots AW, Idris M, van Schooten FJ, van der Vliet A. Redox Imbalance in Idiopathic Pulmonary Fibrosis: A Role for Oxidant Cross-Talk Between NADPH Oxidase Enzymes and Mitochondria. Antioxid Redox Signal 2019;31:1092-115. [PMID: 30793932 DOI: 10.1089/ars.2019.7742] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 7.0] [Reference Citation Analysis]
42 Saghir SAM, Al-Gabri NA, Khafaga AF, El-Shaer NH, Alhumaidh KA, Elsadek MF, Ahmed BM, Alkhawtani DM, Abd El-Hack ME. Thymoquinone-PLGA-PVA Nanoparticles Ameliorate Bleomycin-Induced Pulmonary Fibrosis in Rats via Regulation of Inflammatory Cytokines and iNOS Signaling. Animals (Basel) 2019;9:E951. [PMID: 31717986 DOI: 10.3390/ani9110951] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
43 Andries A, Rozenski J, Vermeersch P, Mekahli D, Van Schepdael A. Recent progress in the LC-MS/MS analysis of oxidative stress biomarkers. Electrophoresis 2021;42:402-28. [PMID: 33280143 DOI: 10.1002/elps.202000208] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]